A.i.r. Platform - Unlimited customization accelerated

Auto-Injectors. Reimagined to Your Custom Needs. Current auto-injector customization models offer very constrained flexibility – and come with serious time-to-market and cost implications. That’s why we’re excited to bring you the Auto-injector Reimagined Platform (A.i.r. Platform™). Built around a flexible core engine design, the platform empowers Pharma companies to achieve a new level of device customization. With the industry’s most extensive range of options to meet specific patient needs and drug profiles, A.i.r. offers a smarter and safer path to market for combination product innovators. This is the paradigm-shifting customization opportunity that patients, Pharma companies and the auto-injector industry have been waiting for. Customized to Fit Your Auto-Injector Needs Built on insights from 14 disease areas, A.i.r. addresses gaps clinicians and patients experience with today’s auto-injectors, especially for rare diseases and niche patient populations where off-the-shelf solutions don’t fit. FDA and customer data echoed these challenges, including incomplete injections, activation issues, grip endurance, cap release and patient use. The result is a highly customizable platform that helps pharma clients develop a branded, ownable device faster than starting from scratch. Supported by End-to-End Expertise When you choose A.i.r. from MGS, you’re not just getting an auto-injector. You’re getting the support of a global end-to-end partner. MGS